Viewing StudyNCT02829541



Ignite Creation Date: 2024-05-06 @ 8:49 AM
Last Modification Date: 2024-10-26 @ 12:05 PM
Study NCT ID: NCT02829541
Status: COMPLETED
Last Update Posted: 2017-03-15
First Post: 2016-07-08

Brief Title: A Phase 1 Single-Ascending-Dose Safety Tolerability PharmacokineticPK and PharmacodynamicPD Study of BIIB068 in Healthy Participants
Sponsor: Biogen
Organization: Biogen

Conditions & Keywords Data

Conditions:
Name
Systemic Lupos Erythematosus SLE
Keywords:
Name View
Single Ascending Dose SAD Healthy Volunteers View